1. Benjamin EJ, Blaha MJ, Chiuve SE, et al. Heart disease and stroke statistics – 2017 update: a report from the American Heart Association. Circulation 2017;135(10):e146–e603.
Crossref
Medline
2. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2017 November 7 (Epub ahead of print).
3. Victor RG, Leonard D, Hess P, et al. Factors associated with hypertension awareness, treatment, and control in Dallas County, Texas. Arch Intern Med 2008;168:1285–1293.
4. Victor RG, Ravenell JE, Freeman A, et al. Effectiveness of a barber-based intervention for improving hypertension control in black men: the BARBER-1 study: a cluster randomized trial. Arch Intern Med 2011;171:342–350.
-
- Crossref
- Medline
5. Rader F, Elashoff RM, Niknezhad S, Victor RG. Differential treatment of hypertension by primary care providers and hypertension specialists in a barber-based intervention trial to control hypertension in Black men. Am J Cardiol 2013;112:1421–1426.
-
- Crossref
- Medline
6. Jaffe MG, Lee GA, Young JD, Sidney S, Go AS. Improved blood pressure control associated with a large-scale hypertension program. JAMA 2013;310:699–705.
7. Zullig LL, Bosworth HB. Behavioral interventions to improve hypertension control in the Veterans Affairs healthcare system. J Clin Hypertens (Greenwich) 2014;16:827–837.
-
- Crossref
- Medline
8. Khanna RR, Victor RG, Bibbins-Domingo K, Shapiro MF, Pletcher MJ. Missed opportunities for treatment of uncontrolled hypertension at physician office visits in the United States, 2005 through 2009. Arch Intern Med 2012;172:1344–1345.
-
- Crossref
- Medline
9. Fontil V, Pletcher MJ, Khanna R, Guzman D, Victor R, Bibbins-Domingo K. Physician underutilization of effective medications for resistant hypertension at office visits in the United States: NAMCS 2006-2010. J Gen Intern Med 2014;29:468–476.
-
- Crossref
- Medline
10. Pavlik VN, Chan W, Hyman DJ, et al. Designing and evaluating health systems level hypertension control interventions for African-Americans: lessons from a pooled analysis of three cluster randomized trials. Curr Hypertens Rev 2015;11:123–131.
-
- Crossref
- Medline
11. Whelton PK, Einhorn PT, Muntner P, et al. Research needs to improve hypertension treatment and control in African Americans. Hypertension 2016;68:1066–1072.
-
- Crossref
- Medline
12. Santschi V, Chiolero A, Colosimo AL, et al. Improving blood pressure control through pharmacist interventions: a meta-analysis of randomized controlled trials. J Am Heart Assoc 2014;3(2):e000718–e000718.
-
- Crossref
- Medline
13. Cheema E, Sutcliffe P, Singer DR. The impact of interventions by pharmacists in community pharmacies on control of hypertension: a systematic review and meta-analysis of randomized controlled trials. Br J Clin Pharmacol 2014;78:1238–1247.
-
- Crossref
- Medline
14. Carter BL. Primary care physician-pharmacist collaborative care model: strategies for implementation. Pharmacotherapy 2016;36:363–373.
-
- Crossref
- Medline
15. Tsuyuki RT, Houle SK, Charrois TL, et al. Randomized trial of the effect of pharmacist prescribing on improving blood pressure in the community: the Alberta Clinical Trial in Optimizing Hypertension (RxACTION). Circulation 2015;132:93–100.
-
- Crossref
- Medline
16. Anderegg MD, Gums TH, Uribe L, Coffey CS, James PA, Carter BL. Physician-pharmacist collaborative management: narrowing the socioeconomic blood pressure gap. Hypertension 2016;68:1314–1320.
-
- Crossref
- Medline
17. Svarstad BL, Kotchen JM, Shireman TI, et al. Improving refill adherence and hypertension control in black patients: Wisconsin TEAM trial. J Am Pharm Assoc (2003) 2013;53:520–529.
-
- Crossref
- Medline
18. Carter BL, Ardery G. Avoiding pitfalls with implementation of randomized controlled multicenter trials: strategies to achieve milestones. J Am Heart Assoc 2016;5(12):e004432–e004432.
-
- Crossref
- Medline
19. Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. Int J Surg 2011;9:672–677.
-
- Crossref
- Medline
20. Eldridge SM, Ashby D, Feder GS, Rudnicka AR, Ukoumunne OC. Lessons for cluster randomized trials in the twenty-first century: a systematic review of trials in primary care. Clin Trials 2004;1:80–90.
-
- Crossref
- Medline
21. Roush GC, Ernst ME, Kostis JB, Tandon S, Sica DA. Head-to-head comparisons of hydrochlorothiazide with indapamide and chlorthalidone: antihypertensive and metabolic effects. Hypertension 2015;65:1041–1046.
-
- Crossref
- Medline
22. Kaplan NM. Indapamide: is it the better diuretic for hypertension? Hypertension 2015;65:983–984.
-
- Crossref
- Medline
23. Anwar YA, Tendler BE, McCabe EJ, Mansoor GA, White WB. Evaluation of the Datascope Accutorr Plus according to the recommendations of the Association for the Advancement of Medical Instrumentation. Blood Press Monit 1997;2:105–110.
24. Hess PL, Reingold JS, Jones J, et al. Barbershops as hypertension detection, referral, and follow-up centers for black men. Hypertension 2007;49:1040–1046.
-
- Crossref
- Medline
25. Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013;31:1281
–1357.
-
- Crossref
- Medline
26. Dashevsky M, Bernstein SL, Barsky CL, Taylor RA. Agreement between serum assays performed in ED point-of-care and hospital central laboratories. West J Emerg Med 2017;18:403–409.
-
- Crossref
- Medline
27. Glasgow RE, Wagner EH, Schaefer J, Mahoney LD, Reid RJ, Greene SM. Development and validation of the Patient Assessment of Chronic Illness Care (PACIC). Med Care 2005;43:436–444.
-
- Crossref
- Medline
28. Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract 2012;120(4):c179–c184.
29. Hayes RJ, Moulton LH. Cluster randomised trials. Boca Raton, FL: Chapman Hall/CRC, 2009.
30. Everitt BS, Landau S, Leese M, Stahl D. Cluster analysis. 5th ed. Chichester, England: John Wiley, 2011.
31. Elashoff RM, Li G, Li N. Joint modeling of longitudinal and time-to-event data. Boca Raton, FL: Chapman Hall/CRC, 2017.
32. Merzel C, D’Afflitti J. Reconsidering community-based health promotion: promise, performance, and potential. Am J Public Health 2003;93:557–574.
-
- Crossref
- Medline
33. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289:2560–2572.
34. James PA, Oparil S, Carter BL, et al. 2014 Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014;311:507–520.
35. Franklin SS, O’Brien E, Staessen JA. Masked hypertension: understanding its complexity. Eur Heart J 2017;38:1112–1118.
36. The SPRINT Research Group. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 2015;373:2103–2116.
37. Carnethon MR, Pu J, Howard G, et al. Cardiovascular health in African Americans: a scientific statement from the American Heart Association. Circulation 2017;136(21):e393–e423.
-
- Crossref
- Medline
